Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
- PMID: 18355776
- DOI: 10.1016/j.ajog.2008.01.037
Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
Abstract
Objective: The Rotterdam criteria extend the phenotypic spectrum of polycystic ovary syndrome (PCOS). We characterized endocrine and metabolic differences among women meeting the National Institutes of Health (NIH) definition for PCOS vs two novel phenotypes established by the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine definition.
Study design: Endocrine and metabolic data from a retrospective analysis of 160 age- and weight-matched women with PCOS and 23 controls were compared. Insulin sensitivity indices were correlated with androgens, gonadotropins, and lipids within each phenotype.
Results: Ovarian and adrenal androgens were highest in the NIH-defined PCOS group, lowest in the nonhyperandrogenic PCOS group, and intermediate in the hyperandrogenic ovulatory PCOS population. Insulin sensitivity indices, gonadotropins, and lipids were similar across all PCOS phenotypes. The magnitude of insulin resistance correlated with free testosterone only in the NIH-defined group.
Conclusion: Androgen levels are the major distinguishing endocrine feature differentiating phenotypic expressions of PCOS. Hyperinsulinemia correlates with free testosterone levels only in traditional NIH-defined women with PCOS.
Similar articles
-
Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.Metab Syndr Relat Disord. 2011 Oct;9(5):375-80. doi: 10.1089/met.2011.0019. Epub 2011 Jun 9. Metab Syndr Relat Disord. 2011. PMID: 21657888
-
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.Clin Endocrinol (Oxf). 2007 Apr;66(4):513-7. doi: 10.1111/j.1365-2265.2007.02764.x. Clin Endocrinol (Oxf). 2007. PMID: 17371468
-
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.Clin Endocrinol (Oxf). 2008 Jul;69(1):52-60. doi: 10.1111/j.1365-2265.2007.03145.x. Epub 2008 Jul 1. Clin Endocrinol (Oxf). 2008. PMID: 18034780
-
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Hum Reprod Update. 2009 Jul-Aug;15(4):477-88. doi: 10.1093/humupd/dmp008. Epub 2009 Mar 11. Hum Reprod Update. 2009. PMID: 19279045 Review.
-
Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.Gynakol Geburtshilfliche Rundsch. 2008;48(1):9-15. doi: 10.1159/000111465. Epub 2008 Jan 17. Gynakol Geburtshilfliche Rundsch. 2008. PMID: 18209494 Review.
Cited by
-
Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis.Cureus. 2022 Dec 9;14(12):e32351. doi: 10.7759/cureus.32351. eCollection 2022 Dec. Cureus. 2022. PMID: 36628015 Free PMC article. Review.
-
Metabolic Syndrome among Patients with Polycystic Ovarian Syndrome Presenting to a Tertiary Care Hospital: A Descriptive Cross-Sectional Study.JNMA J Nepal Med Assoc. 2022 Feb 15;60(246):137-141. doi: 10.31729/jnma.7221. JNMA J Nepal Med Assoc. 2022. PMID: 35210633 Free PMC article.
-
Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.Hum Reprod. 2010 Jan;25(1):204-11. doi: 10.1093/humrep/dep363. Epub 2009 Oct 24. Hum Reprod. 2010. PMID: 19855107 Free PMC article.
-
The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study.Reprod Biol Endocrinol. 2011 Mar 25;9:39. doi: 10.1186/1477-7827-9-39. Reprod Biol Endocrinol. 2011. PMID: 21435276 Free PMC article.
-
Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis.Hum Reprod Update. 2024 Jan 3;30(1):109-130. doi: 10.1093/humupd/dmad027. Hum Reprod Update. 2024. PMID: 37804097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical